Kahraman, S. Et Al. 2024. Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study. BMC CANCER , vol.24 , 1-10.

Kahraman, S., Hizal, M., Demirel, B. C., Guven, D. C., Gumusay, O., Uluc, B. O., ... Bayram, E.(2024). Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study. BMC CANCER , vol.24, 1-10.

Kahraman, Seda Et Al. "Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study," BMC CANCER , vol.24, 1-10, 2024

Kahraman, Seda Et Al. "Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study." BMC CANCER , vol.24, pp.1-10, 2024

Kahraman, S. Et Al. (2024) . "Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study." BMC CANCER , vol.24, pp.1-10.

@article{article, author={Seda Kahraman Et Al. }, title={Activity of CDK4/6 inhibitors and parameters affecting survival in elderly patients in age-subgroups: Turkish Oncology Group (TOG) retrospective study}, journal={BMC CANCER}, year=2024, pages={1-10} }